Abpro Holdings, Inc. (ABP)
NASDAQ: ABP · Real-Time Price · USD
6.63
-0.18 (-2.64%)
Nov 28, 2025, 4:00 PM EST - Market closed

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024
Period Ending
Dec '24
Novel Antibodies
183.00K

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024
Period Ending
Dec '24
United States
183.00K